Keywords: USA, Patents, Biosimilars, Congress, GPha, NEJM

NEJM calls for US Obama to encourage Congress to adopt exclusivity periods for biopharmaceuticals similar to those in Hatch-Waxman Act

Article | 16 October 2009

US President Barack Obama should encourage amendments that would give the Food and Drug Administration the mandate to evaluate and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in